Form 8-K - Current report:
SEC Accession No. 0001005286-24-000119
Filing Date
2024-08-21
Accepted
2024-08-21 16:07:47
Documents
15
Period of Report
2024-08-15
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lndc-20240815.htm   iXBRL 8-K 84114
2 EX-3.1 exhibit31-lfcrxcharteramen.htm EX-3.1 13802
3 EX-10.1 exhibit101-formofamendment.htm EX-10.1 134799
  Complete submission text file 0001005286-24-000119.txt   401041

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lndc-20240815.xsd EX-101.SCH 1983
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lndc-20240815_lab.xml EX-101.LAB 22788
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lndc-20240815_pre.xml EX-101.PRE 13126
17 EXTRACTED XBRL INSTANCE DOCUMENT lndc-20240815_htm.xml XML 2790
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0526
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 241228815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)